Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
VIA-3196
DRUG
2 trials
Sponsors
Madrigal Pharmaceuticals, Inc.
Conditions
Drug Safety
Phase 1
Ascending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects
Completed
NCT01367873
Madrigal Pharmaceuticals, Inc.
Drug Safety
Start: 2011-06-30
End: 2011-10-31
Updated: 2023-08-22
Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects
Completed
NCT01519531
Madrigal Pharmaceuticals, Inc.
Drug Safety
Start: 2012-01-31
End: 2012-11-30
Updated: 2012-12-06
Related Papers
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist.
2013-08-21
112 citations